Wednesday March 4Th, 2020 Loews Coronado Bay Resort, San Diego, California
Total Page:16
File Type:pdf, Size:1020Kb
Monday March 2nd – Wednesday March 4th, 2020 Loews Coronado Bay Resort, San Diego, California Presents 1 Contents Americas Antibody Congress 2020 ............................................................................................................................................................................... 3 Speakers ..................................................................................................................................................................................................................... 3 Day 1 – Monday March 2nd 2020 ............................................................................................................................................................................... 7 Day 2 – Tuesday March 3rd 2020 .............................................................................................................................................................................. 16 Day 3 – Wednesday March 4th 2020 ........................................................................................................................................................................ 28 World Immunotherapy Congress USA 2019 ............................................................................................................................................................... 35 Speakers ................................................................................................................................................................................................................... 35 Day 1 – Monday March 2nd 2020 ............................................................................................................................................................................. 39 Day 2 – Tuesday March 3rd 2020 .............................................................................................................................................................................. 49 Day 3 – Wednesday March 4th 2020 ........................................................................................................................................................................ 64 World Biosimilar Congress USA 2020 ......................................................................................................................................................................... 71 Advisory board ......................................................................................................................................................................................................... 71 Confirmed speakers.................................................................................................................................................................................................. 71 Workshop speakers .................................................................................................................................................................................................. 73 Day 1 – Monday, March 2nd 2020 ............................................................................................................................................................................ 74 Day 2 – Tuesday, March 3rd 2020 ............................................................................................................................................................................. 77 Day 3 – Wednesday, March 4th 2020 ....................................................................................................................................................................... 82 Festival of Biologics USA - Workshop agenda ............................................................................................................................................................ 86 Day 1 - Monday March 2nd 2020 .............................................................................................................................................................................. 86 Day 2 - Tuesday March 3rd 2020 .............................................................................................................................................................................. 87 2 Americas Antibody Congress 2020 Advisory board Marilyn Kehry, Vice President, Cell and Functional Biology, AnaptysBio Jeffrey Froude, Major, Stm, Vaccines and Therapeutics Division, Defence Threat Reduction Agency Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme John Delaney, Director, Research Technologies and Collaborations, Amgen Andrew Korytko, Research Advisor, Group Leader, Protein Engineering, Eli Lilly and Company Vaughn Smider, Professor, The Applied Biomedical Science Institute Jae Sly, Chief Business Officer, LigaTrap Technologies LLC Speakers Aaron Sato, Chief Scientific Officer, Twist Biopharma, a division of Amrik Basran, Chief Scientific Officer, Avacta Twist Bioscience Amy Jenkins, Programme Manager, DARPA Al Tsang, Chief Scientific Officer, Precision Biologics Andrea Ferrante, Principal Research Scientist, Eli Lilly and Company Alexey Berezhnoy, Scientist II, MacroGenics Andres Perez Bay, Senior Staff Scientist, Regeneron 3 Andrew Korytko, Research Advisor, Group Leader, Protein Elizabeth Brunk, Postdoc Fellow, UCSD Moores Cancer Center Engineering, Eli Lilly and Company Erica Ollmann Saphire, Professor, La Jolla Institute for Immunology Andrew Polson, Principal Scientist, Genentech Ethan Laudermilch, Post-Doc, Albert Einstein College of Medicine Andrew Tsourkas, Professor of Bioengineering, University of Eugene Zhukovsky, Chief Scientific Officer, BIOMUNEX Pennsylvania Pharmaceuticals Anthony Mire-Sluis, Head of Global Quality, AstraZeneca Ezio Bonvini, Chief Scientific Officer, MacroGenics Anton Rosenbaum, Senior Scientist, Clinical Immunology & Fabiana Zappala, PhD Student, University of Pennsylvania Bioanalysis, AstraZeneca Feng Wang, Associate Director, Principal Investigator, Institute of Ariel Wirchnianski, PhD Candidate, Albert Einstein College of Biophysics, Chinese Academy of Sciences Medicine Francisco Ylera, R&D Team Leader, New Technologies, Bio-Rad Arunan Kaliyaperumal, Research Fellow, Eli Lilly and Company Laboratories Bellos Hadjivassiliou, Senior Scientist, Bristol-Myers Squibb Gary Starling, Associate Vice President, Protein Science, Merck Bob DuBridge, Senior Vice President of Research Discovery, Maverick Greg Babcock, Vice President, Research, Visterra Inc Therapeutics Gregory Weiss, Professor, University of California Irvine Brandon Dekosky, Assistant Professor, The University of Kansas Gunnar Kaufmann, Chief Scientific Officer, Oncternal Therapeutics Brandon Ruotolo, Professor, Chemistry, University of Michigan Haruki Hasegawa, Principal Scientist, Department of Therapeutic Brian Kay, Professor, Department of Biological Sciences, LAS Discovery, Amgen Distinguished Professor & University Scholar, University of Illinois at Harun Rashid, Senior Principal Scientist, Molecular Technology, Ambrx Chicago Helen Schiltz, Program Officer, Therapeutics Development, National Bronwyn M. Gunn, Assistant Professor, Paul G. Allen School of Global Institute of Health, NIAID Animal Health at Washington State University Hiroaki Suga, Professor, The University of Tokyo Bruce Keyt, CSO, IGM Biosciences Hongshan Li, Marketing Applications Manager, FortéBio C. Russell Cruz, Assistant Professor, Children’s National Hospital Ian Wilson, Hansen Professor of Structural Biology, Skaggs Institute for Chad Swanson, Senior Director, Neurology Business Group, Eisai Chemical Biology, The Scripps Research Institute Christopher Bahl, Head of Protein Design, Institute for Protein Isabelle Turbica, Associate Professor, Paris-Sud University Innovation Itay Levin, Director of Antibody Engineering, Biolojic Design David Boucher, Chief, Antivirals & Antitoxins, Biomedical Advanced Ivan Mascanfroni, Senior Scientist III, Immunology Biologics, Abbvie Research and Development Authority (BARDA) Bioresearch Centre David Busch, Senior Scientist, Merck Jack Ragheb, Senior Medical Fellow, Immunology, Eli Lilly & Company David Dornan, Senior Vice President of Research, Bolt Biotherapeutics Jae Sly, Chief Business Officer, LigaTrap Technologies LLC David Fontana, Head Strategic Alliance & JCAR017 Program Lead, Juno James Legg, Vice President, Research & Development, Crescendo Therapeutics Biologics Dawn Wofford, Regulatory Affairs Director, Cytovance Biologics Jared Delmar, Scientist I, AstraZeneca Denise Haslwanter, Research Fellow, Albert Einstein College of Javier Chaparro-Riggers, Executive Director, Pfizer Medicine Dian Su, Scientist, Genentech Jeffrey Froude, Major, Stm, Vaccines and Therapeutics Division, Derek Wilson, Director, Wilson Lab, York University Defence Threat Reduction Agency Elisabeth Nyakatura, Research Assistant Professor, Albert Einstein Jintang He, Scientist, Genentech College of Medicine Joan Shen, Head of Research and Development, I-Mab Biopharma 4 Johannes Brozy, Senior Associate Scientist, Bite Technology, Amgen Partha Chowdhury, Senior Director and Head, Antibody Discovery, John Delaney, Director, Research Technologies and Collaborations, Sanofi Genzyme Amgen John Hood, Chairman, Endeavour Biomedicines Pascal Touchon, President and CEO, Atara Biotherapeutics John Lambert, Consultant, Honorary Professor, Queen’s University, Patrick Wilson, Professor, Department of Medicine/Rheumatology, Belfast, Former CSO, ImmunoGen The University of